Several other Protease Inhibitors are being developed as well, including the nightmare experience I had with the Protease Inhibitor by BI. Still, I believe I will be cured so it does work, and my side effects were more extreme than anyone else in the clinical trials. Lucky boy!
Overall, the innovation in the Hepatitis C treatment arena and thus the overall marketplace are nothing less than stunning. Within a few years, it looks like Interferon and Ribavirin will be removed from the treatment regimen, replaced by a Protease Inhibitor that covers all the bases. How great is that!
But let me be clear about my response to these incredible innovations. Despite the severity of my side effects, I am not bitter about my decision to enter the clinical trial and get treatment now. It was the right decision to make at the time, and my bad luck in regards to the side effects was just that - simple bad luck with no dark magic or evil curses. Hey, sometimes we roll the bones and we come up aces and sometimes we just crap out.
Such is life, and I choose to free myself from the burden of bitterness and regret. What's the point?! It's not like I was playing with loaded dice and got screwed. Sometimes the universe works for you and sometimes you work hard for the universe.
I wish we had more control, but, as the French say, C'est La Vie!
 |
| Drug Research Is Big Business: 4-6 Million HCV Infected Adults In The US |
Overall, the innovation in the Hepatitis C treatment arena and thus the overall marketplace are nothing less than stunning. Within a few years, it looks like Interferon and Ribavirin will be removed from the treatment regimen, replaced by a Protease Inhibitor that covers all the bases. How great is that!
But let me be clear about my response to these incredible innovations. Despite the severity of my side effects, I am not bitter about my decision to enter the clinical trial and get treatment now. It was the right decision to make at the time, and my bad luck in regards to the side effects was just that - simple bad luck with no dark magic or evil curses. Hey, sometimes we roll the bones and we come up aces and sometimes we just crap out.
Such is life, and I choose to free myself from the burden of bitterness and regret. What's the point?! It's not like I was playing with loaded dice and got screwed. Sometimes the universe works for you and sometimes you work hard for the universe.
I wish we had more control, but, as the French say, C'est La Vie!
If you choose to hold tight and carry the bitter weight of your regrets, do not ask why their no fluidity or rhythm to your life. What the hell do you expect when you are so overwhelmed by the horrors of the past that you sacrifice the freedom to live in the present.
Here is the article below about some of the new Hep C innovations:
2011 has brought patients with hepatitis C not one but two new groundbreaking medicines to treat the condition. Merck’s Victrelis (boceprevir) and Johnson & Johnson/Vertex’s Incivek (telaprevir) were both launched in the US in May.
The drugs are both oral protease inhibitors, and promise to significantly improve treatment when added to the current standard treatments for the disease. An estimated 270-300 million people throughout the world have the disease.
Analysts predict Incivek will prevail because it has shown a higher cure rate, and a simpler and faster simpler dosing regimen. But Vertex, which has never launched a drug before, will have to overcome the might of Merck and its new US marketing partner Roche.
Vertex’s belief in the superiority of its product is reflected in its price, which is $49,200 for a 12-week course. This cost is much higher than Victrelis, and is equivalent to the price of a whole 48-week treatment with Merck’s drug.
Incivek has had the best start, earning $420 million between May to October, while the same period saw Victrelis earn a more modest $31 million.
No comments:
Post a Comment